A pilot trial of quantitative Epstein-Barr virus polymerase chain reaction in patients undergoing treatment for their malignancy: potential use of Epstein-Barr virus polymerase chain reaction in multiple cancer types
Leuk Lymphoma. 2015 May;56(5):1530-2.
doi: 10.3109/10428194.2014.963577.
Epub 2014 Nov 5.